Project Grant HT94252410082
Award Date 1/15/24
Completion Date 1/14/27
Dollars Obligated $679K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
- This Project Grant award for $435,876.00, awarded on March 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Temple University-Of The Commonwealth System Of Higher Education to investigate a novel therapeutic target for lymphedema. The research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative medical solutions to address...
- This $1,585,000 Project Grant awarded by the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding research at Temple University to target lymphatic chemokine signaling in order to promote lymphangiogenesis for the treatment of lymphedema. The research project aims to transform healthcare for military service members, veterans, and the public by developing innovative medical solutions to address critical health challenges. The award has a...
- The U.S. Defense Health Agency awarded a $700,788 Project Grant to The Institute For Cancer Research, a non-profit subsidiary of Temple University, under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project to study the targeting of the nuclear necroptosis pathway in the pancreatic cancer microenvironment. As a prime grantee, The Institute For Cancer Research will conduct preclinical testing, biomarker analysis, and other specialized...
- The U.S. Defense Health Agency awarded a $1,880,000 Project Grant to The Institute for Cancer Research, a non-profit subsidiary of Temple University, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project to study the SRPK1-AKT signaling axis in endometrial cancer. As a prime grantee, The Institute for Cancer Research will conduct preclinical testing and analysis to develop new approaches for cancer prevention and...
- This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
- Federal Project Grant Award Summary Drexel University received a $609,168 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2027. The award supports research on human organotypic brain slice cultures to investigate brain-metastatic melanoma and immune infiltration. This research initiative addresses critical biomedical challenges relevant to military health by developing...
- The Department of the Army Medical Command awarded a $1,188,750.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Temple University to support research aimed at identifying therapeutic peptide drugs for regenerating visual pathways. The award, effective September 15, 2024, will fund this initiative over a 3-year period through September 14, 2027. As a prominent public research university, Temple University has extensive experience conducting advanced...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a $633,750 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2028. This award supports research investigating the interplay between sensory neurons and natural killer (NK) cells during breast cancer metastatic dormancy. The research aims to advance understanding of mechanisms that suppress breast...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,128,000 Project Grant to The Institute For Cancer Research to conduct research on "Restoring PALB2 Function as a Mechanism of PARP1 Resistance in BRCA1-Mutant EOC". The award, with a performance period from July 1, 2024 to June 30, 2028, supports innovative scientific research aimed at improving health outcomes for military service members, veterans, and the broader...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...